sjGold2018-06-23 01:37
$Interpace Diagnostics Group, Inc.(IDXG)$ Ladenburg Thalmann的分析师对Interpace Diagnostics Group,Inc.(纳斯达克股票代码:IDXG)进行了买入评级。 InterSpace Diagnostics的价格目标定为2.25美元。 Interpace Diagnostics股价周四收于0.86美元。查看全文
Just-a-Novice2018-02-22 16:41
$Interpace Diagnostics Group, Inc.(IDXG)$
请教大家一个或许很白痴的问题,如果有人知道,还请不吝告知:
为什么批准IDXG test的总是“New York State Department of Health”?
难道不需要FDA批的吗?
被New York State Department of Health批了,应该是只能在New York State...查看全文
$Interpace(IDXG)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-21-007927 Act: 34 Size: 131 KB 网页链接
$Interpace(IDXG)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001493152-21-007622 Act: 34 Size: 39 KB 网页链接
$Interpace(IDXG)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-21-007629 Act: 34 Size: 8 MB 网页链接
$Interpace(IDXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-005913 Size: 7 KB 网页链接
$Interpace(IDXG)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001171520-21-000113 Act: 34 Size: 46 KB 网页链接
$Interpace(IDXG)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001420506-21-000362 Size: 8 KB 网页链接
$Interpace(IDXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001420506-21-000363 Size: 18 KB 网页链接
$Interpace(IDXG)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001493152-21-004756 Act: 34 Size: 55 KB 网页链接
$Interpace(IDXG)$ 8-K Current report, items 3.01, 7.01, 8.01, and 9.01 Accession Number: 0001493152-21-004159 Act: 34 Size: 90 KB 网页链接
$Interpace(IDXG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-21-000123 Act: 34 Size: 60 KB 网页链接